A recent study has shown that MUC4 is a good candidate marker for early diagnosis of pancreatic cancer in fine-needle aspirates, exhibiting a 91% sensitivity and 100% specificity (Jhala et al, 2006). Here, MUC4 is linked to pancreatic neoplasm.